150 related articles for article (PubMed ID: 26050796)
61. Comparison of the prediction performance of different warfarin dosing algorithms based on Chinese patients.
Xie C; Xue L; Zhang Y; Zhu J; Zhou L; Hang Y; Ding X; Jiang B; Miao L
Pharmacogenomics; 2020 Jan; 21(1):23-32. PubMed ID: 31849278
[No Abstract] [Full Text] [Related]
62. Verification of five pharmacogenomics-based warfarin administration models.
Lin M; Yu L; Qiu H; Wang Q; Zhang J; Song H
Indian J Pharmacol; 2016; 48(3):258-63. PubMed ID: 27298494
[TBL] [Abstract][Full Text] [Related]
63. Warfarin pharmacogenomics and African ancestry.
Price ET
Blood; 2015 Jul; 126(4):434-6. PubMed ID: 26206946
[TBL] [Abstract][Full Text] [Related]
64. Warfarin Pharmacogenetics Reevaluated: Subgroup Analysis Reveals a Likely Underestimation of the Maximum Pharmacogenetic Benefit by Clinical Trials.
Stack G; Maurice CB
Am J Clin Pathol; 2016 May; 145(5):671-86. PubMed ID: 27247371
[TBL] [Abstract][Full Text] [Related]
65. Evaluation of the predictive performance of Bayesian dosing for warfarin in Chinese patients.
Dong J; Shi GH; Lu M; Huang S; Liu YH; Yao JC; Li WY; Li LX
Pharmacogenomics; 2019 Feb; 20(3):167-177. PubMed ID: 30777785
[TBL] [Abstract][Full Text] [Related]
66. Quantitative Assessment of CYP2C9 Genetic Polymorphisms Effect on the Oral Clearance of S-Warfarin in Healthy Subjects.
Shaul C; Blotnick S; Muszkat M; Bialer M; Caraco Y
Mol Diagn Ther; 2017 Feb; 21(1):75-83. PubMed ID: 27878474
[TBL] [Abstract][Full Text] [Related]
67. Application of a pharmacogenetic-based warfarin dosing algorithm derived from British patients to predict dose in Swedish patients.
Hatch E; Wynne H; Avery P; Wadelius M; Kamali F
J Thromb Haemost; 2008 Jun; 6(6):1038-40. PubMed ID: 18419746
[No Abstract] [Full Text] [Related]
68. Comparison of multivariate linear regression and a machine learning algorithm developed for prediction of precision warfarin dosing in a Korean population.
Nguyen VL; Nguyen HD; Cho YS; Kim HS; Han IY; Kim DK; Ahn S; Shin JG
J Thromb Haemost; 2021 Jul; 19(7):1676-1686. PubMed ID: 33774911
[TBL] [Abstract][Full Text] [Related]
69. Novel polymorphisms in CYP4F2 and VKORC1 may lead to adaptations to the warfarin-dosage algorithm.
Pharmacogenomics; 2013 Jul; 14(9):1003. PubMed ID: 23837473
[No Abstract] [Full Text] [Related]
70. Pharmacogenetic-Guided Algorithm to Improve Daily Dose of Warfarin in Elder Han-Chinese Population.
Ren Y; Yang C; Chen H; Dai D; Wang Y; Zhu H; Wang F
Front Pharmacol; 2020; 11():1014. PubMed ID: 32754031
[TBL] [Abstract][Full Text] [Related]
71. Identification of gene modules associated with warfarin dosage by a genome-wide DNA methylation study.
Luo Z; Liu R; Sun B; Zhou X; Liu Z; Zhou H; Xu H; Li X; Zhang W
Pharmazie; 2018 May; 73(5):288-293. PubMed ID: 29724296
[TBL] [Abstract][Full Text] [Related]
72. Pharmacogenetic algorithm for predicting daily dose of warfarin in Caucasian patients of Czech origin.
Tomek A; Růžičková T; Kaplan V; Lacinová Z; Kumstýřová S; Šrámek M; Olšerová A; Janský P; Kolářová T; Neumann J; Schwabová JP; Maťoška V
Drug Metab Pers Ther; 2020 Dec; ():. PubMed ID: 33780197
[TBL] [Abstract][Full Text] [Related]
73. Comparison of warfarin pharmacogenetic dosing algorithms in a racially diverse large cohort.
Shin J; Cao D
Pharmacogenomics; 2011 Jan; 12(1):125-34. PubMed ID: 21174627
[TBL] [Abstract][Full Text] [Related]
74. Genotype-based dosing algorithms for warfarin therapy: data review and recommendations.
Johnson EG; Horne BD; Carlquist JF; Anderson JL
Mol Diagn Ther; 2011 Oct; 15(5):255-64. PubMed ID: 22047153
[TBL] [Abstract][Full Text] [Related]
75. The importance of including African populations in pharmacogenetics studies of warfarin response.
Dandara C; Ndadza A; Soko N
Pharmacogenomics; 2022 Jan; 23(1):1-4. PubMed ID: 34821506
[TBL] [Abstract][Full Text] [Related]
76. Point-Counterpoint: Genotype-Guided Warfarin Therapy.
Lu WJ; Miller NJ
S D Med; 2017 Feb; 70(2):54-56. PubMed ID: 28810086
[No Abstract] [Full Text] [Related]
77. A Bayesian Estimation Framework for Pharmacogenomics Driven Warfarin Dosing: A Comparative Study.
Öztaner SM; Temizel TT; Erdem SR; Özer M
IEEE J Biomed Health Inform; 2015 Sep; 19(5):1724-33. PubMed ID: 25020183
[TBL] [Abstract][Full Text] [Related]
78. Pharmacogenomics research and clinical implementation in Brazil.
Rodrigues-Soares F; Suarez-Kurtz G
Basic Clin Pharmacol Toxicol; 2019 May; 124(5):538-549. PubMed ID: 30589990
[TBL] [Abstract][Full Text] [Related]
79. Pharmacogenetics of coumarin anticoagulants in Brazilians.
Suarez-Kurtz G; Botton MR
Expert Opin Drug Metab Toxicol; 2015 Jan; 11(1):67-79. PubMed ID: 25345887
[TBL] [Abstract][Full Text] [Related]
80. [Which of algorithms of warfarin dosing based on results of pharmacogenetic testing is suitable for patients in Russia].
Sychev DA; Antonov IM; Kropacheva ES; Panchenko EP
Kardiologiia; 2010; 50(4):35-7. PubMed ID: 20459419
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
